Literatur-DB: Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.
| Titel: | Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer. |
| Kategorien: | Gallengangskarzinom |
| BuchID: | 22 |
| Autor: | Verschiedene |
| ISBN-10(13): | KA |
| Publikationsdatum: | 2013 09 |
| Number of pages: | 0 |
| Sprache: | Nicht spezifiziert |
| Preis: | 0.00 |
| Bewertung: |
|
| Bild: |
zum Original
|
| Beschreibung: |
AbstractBACKGROUND:The aim of this retrospective study was to clarify the safety and efficacy of dendritic cell (DC)-based immunotherapy targeting synthesized peptides, Wilms tumor 1 (WT1) and Mucin 1, cell surface associated (MUC1) for biliary tract cancers (BTCs). Artikel-Nr.: 17(9):1609-17 | PubMed-ID: 23877328 | DOI: 10.1007/s11605-013-2286-2 | ISBN: |
Rezensionen
